Page last updated: 2024-08-16

quipazine and mdl 100907

quipazine has been researched along with mdl 100907 in 7 studies

Research

Studies (7)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (28.57)18.2507
2000's5 (71.43)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Benwell, K; Bickerdike, M; Kennett, G; Knight, AR; Misra, A; Quirk, K; Revell, D1
Barrett, RJ; Sanders-Bush, E; Smith, RL1
Fuller, RW; Hemrick-Luecke, SK1
Evans, DC; Hemrick-Luecke, SK1
Asgari, K; Body, S; Bradshaw, CM; Fone, KC; Rickard, JF; Szabadi, E; Zhang, Z1
Chandra Sekhar, KV; Krishna, MM; Rao, VS1
Devambatla, RKV; Kumar, MM; Rao, VS; Sekhar, KV1

Other Studies

7 other study(ies) available for quipazine and mdl 100907

ArticleYear
Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
    Naunyn-Schmiedeberg's archives of pharmacology, 2004, Volume: 370, Issue:2

    Topics: Binding Sites; Binding, Competitive; Cell Line; Humans; Radioligand Assay; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Recombinant Proteins; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists

2004
Neurochemical and behavioral evidence that quipazine-ketanserin discrimination is mediated by serotonin2A receptor.
    The Journal of pharmacology and experimental therapeutics, 1995, Volume: 275, Issue:2

    Topics: Animals; Brain Mapping; Discrimination Learning; Dose-Response Relationship, Drug; Fluorobenzenes; Ketanserin; Male; Piperidines; Quipazine; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists

1995
Involvement of 5-HT2A receptors in the elevation of rat serum corticosterone concentrations by quipazine and MK-212.
    European journal of pharmacology, 1996, Sep-12, Volume: 311, Issue:2-3

    Topics: Animals; Corticosterone; Fluorobenzenes; Indoles; Male; Piperidines; Pyrazines; Quipazine; Rats; Rats, Sprague-Dawley; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists; Urea

1996
Comparison of the potency of MDL 100,907 and SB 242084 in blocking the serotonin (5-HT)(2) receptor agonist-induced increases in rat serum corticosterone concentrations: evidence for 5-HT(2A) receptor mediation of the HPA axis.
    Neuropharmacology, 2002, Volume: 42, Issue:2

    Topics: Aminopyridines; Amphetamines; Animals; Corticosterone; Dose-Response Relationship, Drug; Ethylamines; Fluorobenzenes; Hypothalamo-Hypophyseal System; Indoles; Male; Piperazines; Piperidines; Quipazine; Rats; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists; Serotonin Receptor Agonists

2002
Effects of quipazine and m-chlorophenylbiguanide (m-CPBG) on temporal differentiation: evidence for the involvement of 5-HT2A but not 5-HT3 receptors in interval timing behaviour.
    Psychopharmacology, 2005, Volume: 181, Issue:2

    Topics: Animals; Biguanides; Conditioning, Operant; Dose-Response Relationship, Drug; Female; Injections, Intraperitoneal; Injections, Subcutaneous; Ketanserin; Psychometrics; Quipazine; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin, 5-HT3; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Serotonin 5-HT3 Receptor Agonists; Serotonin 5-HT3 Receptor Antagonists; Serotonin Antagonists; Serotonin Receptor Agonists; Task Performance and Analysis; Time Perception; Tropanes

2005
Synthesis and preliminary screening of novel N-{2-[4-(substituted)piperazin-1-yl]-2-oxoethyl}acetamides as potential atypical antipsychotic agents.
    Journal of enzyme inhibition and medicinal chemistry, 2009, Volume: 24, Issue:3

    Topics: Acetamides; Animals; Antipsychotic Agents; Dopamine D2 Receptor Antagonists; Drug Evaluation, Preclinical; Female; Head Movements; Male; Mice; Microwaves; Piperazines; Quipazine; Rats; Receptor, Serotonin, 5-HT2C; Receptors, Dopamine D2; Serotonin 5-HT2 Receptor Antagonists

2009
Synthesis and preliminary pharmacological evaluation of N-2-(4-(4-(2-substitutedthiazol-4-yl) piperazin-1-yl)-2-oxoethyl)acetamides as novel atypical antipsychotic agents.
    Bioorganic & medicinal chemistry letters, 2008, 12-01, Volume: 18, Issue:23

    Topics: Acetamides; Animals; Antipsychotic Agents; Combinatorial Chemistry Techniques; Disease Models, Animal; Head Movements; Mice; Molecular Structure; Motor Activity; Piperazines; Quipazine; Serotonin 5-HT2 Receptor Antagonists

2008